Antimicrobial Agents Practice Questions

Q: What is the therapeutic advantage of penicillin V over penicillin G?

More reliable oral absorption. **Explanation:** The primary therapeutic advantage of **Penicillin V (Phenoxymethylpenicillin)** over **Penicillin G (Benzylpenicillin)** is its **acid stability**, which leads to more reliable oral absorption. 1. **Why Option A is correct:** Penicillin G is acid-labile and is rapidly destroyed by gastric acid, making its oral bioavailability poor and unpredictable (only about 1/3rd is absorbed). In contrast, Penicillin V is **acid-stable**, allowing it to pass through the stomach intact. This results in higher and more consistent plasma concentrations when administered orally. 2. **Why other options are incorrect:** * **Option B:** Neither Penicillin G nor V is resistant to penicillinase (beta-lactamase). Both are degraded by staphylococcal beta-lactamase. * **Option C:** Both drugs have a very short half-life (~30 minutes) and are rapidly excreted by the kidneys via active tubular secretion (80%) and glomerular filtration (20%). * **Option D:** Both drugs have a similar, narrow antibacterial spectrum, primarily targeting Gram-positive cocci (Streptococci) and some Gram-positive bacilli. **High-Yield NEET-PG Pearls:** * **Route of Choice:** Penicillin G is the drug of choice for **Syphilis** (administered parenterally). Penicillin V is used for minor infections like **Streptococcal pharyngitis** or tonsillitis. * **Probenecid Interaction:** Probenecid inhibits the renal tubular secretion of penicillins, thereby increasing their plasma concentration and prolonging their duration of action. * **Repository Forms:** Procaine and Benzathine Penicillin G are long-acting injectable forms designed to delay absorption, not to be confused with the oral stability of Penicillin V.

Q: What single-dose drug is used to treat gonorrhea in a 23-year-old pregnant female with severe amoxicillin sensitivity?

Ceftriaxone. **Explanation:** The treatment of choice for uncomplicated gonococcal infections is a single dose of **Ceftriaxone (Option A)**. According to current CDC and WHO guidelines, Ceftriaxone (500 mg IM) is the preferred agent due to its high efficacy and the rising resistance of *Neisseria gonorrhoeae* to other classes. **Why Ceftriaxone is correct despite "Amoxicillin Sensitivity":** In clinical practice, "severe amoxicillin sensitivity" often refers to a Type I IgE-mediated hypersensitivity (anaphylaxis). While there is a historical concern regarding cross-reactivity between penicillins and cephalosporins, the actual rate is **less than 1%** with third-generation cephalosporins like Ceftriaxone. In pregnancy, Ceftriaxone is considered safe (Category B) and remains the first-line recommendation. **Analysis of Incorrect Options:** * **Clindamycin (B):** This is a lincosamide used primarily for anaerobic infections and Gram-positive cocci; it has no clinical activity against *N. gonorrhoeae*. * **Ciprofloxacin (C):** Fluoroquinolones are no longer recommended for gonorrhea due to widespread resistance. Furthermore, they are generally avoided in pregnancy due to potential risks to fetal cartilage development. * **Spectinomycin (D):** While effective against gonorrhea and safe in pregnancy, it is an alternative agent used only when cephalosporins are contraindicated or unavailable. It is not the primary "drug of choice." **NEET-PG High-Yield Pearls:** * **Dual Therapy:** Historically, Ceftriaxone was paired with Azithromycin. Current guidelines now favor **Ceftriaxone monotherapy (500mg IM)** unless Chlamydia has not been excluded. * **Pregnancy Safety:** Ceftriaxone is the safest and most effective option for pregnant patients. * **Resistance:** Always remember that *N. gonorrhoeae* has developed high-level resistance to Penicillins, Tetracyclines, and Quinolones.

Q: Which of the following is a prodrug of Penciclovir?

Famciclovir. The correct answer is **Famciclovir**. **1. Why Famciclovir is correct:** Famciclovir is a diacetyl 6-deoxy analog of **Penciclovir**. It is an oral prodrug developed to overcome the poor oral bioavailability of Penciclovir [1]. After oral administration, Famciclovir undergoes rapid deacetylation and oxidation in the intestinal wall and liver to be converted into its active form, Penciclovir. Like Acyclovir, it requires viral thymidine kinase for initial phosphorylation to inhibit viral DNA polymerase [1, 2]. It is primarily used for Herpes Zoster (shingles) and genital herpes. **2. Why the other options are incorrect:** * **Valacyclovir:** This is the L-valyl ester prodrug of **Acyclovir**. It has much better oral bioavailability than Acyclovir [2]. * **Valganciclovir:** This is the L-valyl ester prodrug of **Ganciclovir**. It is the drug of choice for oral prophylaxis and treatment of Cytomegalovirus (CMV) retinitis. * **Cidofovir:** This is **not a prodrug**; it is a nucleotide analog (cytidine phosphonate). Unlike the others, it does not require viral phosphorylation and is active against thymidine kinase-deficient strains. **High-Yield Clinical Pearls for NEET-PG:** * **Bioavailability:** Prodrugs like Famciclovir and Valacyclovir were specifically designed to increase oral bioavailability compared to their parent compounds [1, 2]. * **Spectrum:** Famciclovir and Acyclovir are mainly for HSV and VZV; Ganciclovir/Valganciclovir are the gold standard for CMV. * **Mechanism:** All these drugs (except Cidofovir and Foscarnet) require **Viral Thymidine Kinase** for the first step of activation. Resistance usually occurs due to the absence or mutation of this enzyme [1, 2].

Q: A 15-year-old female with HIV infection on antiretroviral therapy presents with nausea, vomiting, and flank pain. Urine microscopy showed rectangular plate and needle-shaped crystals. Serum creatinine was raised. What is the likely cause?

Indinavir. ### Explanation The clinical presentation of nausea, vomiting, flank pain, and acute kidney injury (raised creatinine) in an HIV-positive patient points toward **nephrolithiasis and obstructive uropathy** [1]. **1. Why Indinavir is the Correct Answer:** Indinavir is a Protease Inhibitor (PI) known for its poor solubility at physiological urinary pH. Approximately 20% of the drug is excreted unchanged in the urine. This leads to the formation of **Indinavir crystals**, which are characteristically described as **rectangular plates, fans, or needle-shaped crystals**. These crystals can cause crystalluria, nephrolithiasis (kidney stones), and "sludge" formation, leading to obstructive uropathy and interstitial nephritis. **2. Why the Other Options are Incorrect:** * **Ritonavir (B):** While also a Protease Inhibitor, it is primarily used in low doses as a "booster" for other PIs. It is not typically associated with crystalluria or nephrolithiasis. * **Nevirapine (C):** An NNRTI primarily associated with hepatotoxicity and severe dermatological reactions like Stevens-Johnson Syndrome (SJS), not renal stones. * **Zidovudine (D):** An NRTI whose hallmark side effects are bone marrow suppression (anemia, neutropenia) and myopathy. It does not cause crystal-induced kidney injury. **3. High-Yield Clinical Pearls for NEET-PG:** * **Management:** Indinavir-induced stones are **radiolucent** (not seen on X-ray). Treatment involves vigorous hydration (at least 1.5–2 liters/day) and temporary discontinuation of the drug. * **Other Drugs causing Crystalluria:** Acyclovir (needle-shaped), Sulfonamides (rosette/wheat-sheaf), and Methotrexate. * **Tenofovir (TDF):** Another high-yield HIV drug causing renal issues, but it presents as **Fanconi Syndrome** (proximal tubule dysfunction) rather than stones.

Q: Which of the following drugs is least effective against MRSA?

Meropenem. **Explanation:** The core mechanism of **Methicillin-resistant *Staphylococcus aureus* (MRSA)** resistance is the acquisition of the **mecA gene**, which encodes an altered Penicillin-Binding Protein (**PBP2a**). Most beta-lactam antibiotics, including carbapenems, have a very low affinity for PBP2a, rendering them ineffective. * **Why Meropenem is the correct answer:** Meropenem is a carbapenem. Like almost all beta-lactams (penicillins, cephalosporins, and carbapenems), it cannot bind effectively to the modified PBP2a of MRSA. Therefore, it is clinically ineffective against these strains. (Note: Ceftaroline and Ceftobiprole are the only "advanced-generation" cephalosporins with MRSA activity). * **Why the other options are incorrect:** * **Teicoplanin:** A glycopeptide (similar to Vancomycin) that inhibits cell wall synthesis by binding to the D-Ala-D-Ala terminus. It remains a mainstay for treating MRSA. * **Quinupristin:** A streptogramin (used in combination with Dalfopristin) that inhibits protein synthesis. It is reserved for multidrug-resistant Gram-positive infections, including MRSA and VRSA. * **Linezolid:** An oxazolidinone that inhibits the formation of the 70S initiation complex. It is a high-yield drug for MRSA, especially in cases of pneumonia or skin infections. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for MRSA:** Vancomycin (parenteral). * **Oral drugs for MRSA:** Linezolid, Clindamycin, and Cotrimoxazole. * **Side Effect Alert:** Linezolid is associated with **thrombocytopenia** (with prolonged use) and **Serotonin Syndrome** when co-administered with SSRIs. * **Daptomycin:** Effective against MRSA but **cannot** be used for MRSA pneumonia because it is inactivated by pulmonary surfactant.

Q: What is the oral therapy of choice in MRSA skin infection?

Clindamycin. **Explanation:** **1. Why Clindamycin is the Correct Answer:** Methicillin-resistant *Staphylococcus aureus* (MRSA) is resistant to all beta-lactam antibiotics (except 5th generation cephalosporins) due to the **mecA gene**, which alters Penicillin-Binding Protein (PBP-2a). For community-acquired MRSA (CA-MRSA) skin and soft tissue infections, **Clindamycin** is a preferred oral agent. It works by inhibiting the 50S ribosomal subunit, thereby suppressing bacterial protein synthesis. Notably, it also inhibits the production of toxins (like PVL toxin) often associated with severe MRSA skin infections. **2. Why the Other Options are Incorrect:** * **Dicloxacillin:** This is a penicillinase-resistant penicillin. While effective against MSSA (Methicillin-sensitive *S. aureus*), it is **ineffective** against MRSA because MRSA has altered target sites (PBPs) that Dicloxacillin cannot bind to. * **Quinupristin & Dalfopristin:** These are streptogramins used in combination (Synercid) for multi-drug resistant Gram-positive infections, including MRSA and VRE. However, they are administered **intravenously (IV)** only and are reserved for severe, complicated infections, not as standard oral therapy for skin infections. **3. High-Yield Clinical Pearls for NEET-PG:** * **Oral drugs for CA-MRSA:** Clindamycin, Linezolid, Doxycycline, and Cotrimoxazole (TMP-SMX). * **D-Test:** Before starting Clindamycin, a "D-zone test" is performed to check for inducible clindamycin resistance in strains resistant to Erythromycin. * **Drug of Choice (DOC) for Systemic/Hospital-acquired MRSA:** Vancomycin (IV). * **Newer Oral Agent:** Tedizolid (an oxazolidinone like Linezolid) is also used for MRSA skin infections. * **Mupirocin:** Topical DOC for MRSA colonization in the nares.

Q: Which of the following is NOT a true statement regarding the mechanism of action of the listed antimicrobial agents?

Tetracycline inhibits cell wall synthesis.. ### Explanation The correct answer is **B. Tetracycline inhibits cell wall synthesis.** This statement is false because Tetracyclines are **protein synthesis inhibitors**, not cell wall synthesis inhibitors. #### 1. Why Option B is the Correct Choice (The False Statement) Tetracyclines (e.g., Doxycycline, Minocycline) act by reversibly binding to the **30S ribosomal subunit**. This prevents the attachment of aminoacyl-tRNA to the mRNA-ribosome complex, thereby halting bacterial protein synthesis. They are generally bacteriostatic. #### 2. Analysis of Other Options * **Option A (Chloramphenicol):** This is a true statement. Chloramphenicol binds to the **50S ribosomal subunit** and inhibits the enzyme **peptidyl transferase**, preventing peptide bond formation. * **Option C (Metronidazole):** This is a true statement. Metronidazole is a prodrug activated by anaerobic bacteria (via the pyruvate:ferredoxin oxidoreductase system). Its reduced metabolites create reactive intermediates that cause **DNA strand breakage** and helix destabilization. * **Option D (Penicillin):** This is a true statement. Penicillins are Beta-lactams that bind to **Penicillin-Binding Proteins (PBPs)**, inhibiting the cross-linking of peptidoglycan chains (transpeptidation), leading to bacterial cell lysis. #### 3. NEET-PG High-Yield Clinical Pearls * **Mnemonic for Protein Synthesis Inhibitors:** **"Buy AT 30, CELL at 50"** * **30S inhibitors:** **A**minoglycosides (Bactericidal), **T**etracyclines (Bacteriostatic). * **50S inhibitors:** **C**hloramphenicol, **E**rythromycin (Macrolides), **L**inezolid, **L**incosamides (Clindamycin). * **Tetracycline Side Effects:** Fanconi syndrome (expired tetracyclines), tooth discoloration, and photosensitivity. * **Chloramphenicol Toxicity:** Gray Baby Syndrome (due to deficient glucuronidation) and Bone Marrow Suppression (Aplastic Anemia).

Q: Thalidomide is used in all of the following conditions EXCEPT:

HIV neuropathy. **Explanation:** Thalidomide is an immunomodulatory agent known for its anti-inflammatory and anti-angiogenic properties. The correct answer is **HIV neuropathy** because Thalidomide is actually **contraindicated** in this condition. One of the most significant and dose-limiting side effects of Thalidomide is **peripheral neuropathy** (sensory and symmetrical). Administering it to a patient already suffering from HIV-associated neuropathy would severely exacerbate nerve damage. **Analysis of Options:** * **Erythema Nodosum Leprosum (ENL):** Thalidomide is the drug of choice for Type 2 lepra reactions (ENL). It acts by inhibiting Tumor Necrosis Factor-alpha (TNF-α), which is the primary mediator in this inflammatory state. * **HIV-associated Ulcers:** Thalidomide is highly effective in treating refractory aphthous ulcers in HIV patients due to its potent anti-inflammatory effects. * **Multiple Myeloma:** It is a standard treatment for Multiple Myeloma. Its anti-angiogenic properties (inhibiting VEGF and bFGF) and its ability to induce apoptosis in malignant plasma cells make it a cornerstone of therapy, often used in combination with dexamethasone. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Inhibits TNF-α and angiogenesis. * **Teratogenicity:** It is a notorious human teratogen causing **Phocomelia** (seal-like limbs). It must never be given during pregnancy (Category X). * **Regulatory:** Its use is strictly controlled through programs like STEPS to prevent fetal exposure. * **Other Uses:** It is also used in Behçet’s disease and certain graft-versus-host diseases.

Question 1

What is the therapeutic advantage of penicillin V over penicillin G?

Accepted Answer

More reliable oral absorption

Answer

Greater resistance to penicillinase

Answer

Slower renal excretion

Answer

Broader antibacterial spectrum

Question 2

What single-dose drug is used to treat gonorrhea in a 23-year-old pregnant female with severe amoxicillin sensitivity?

Accepted Answer

Ceftriaxone

Answer

Clindamycin

Answer

Ciprofloxacin

Answer

Spectinomycin

Question 3

Which of the following is a prodrug of Penciclovir?

Accepted Answer

Famciclovir

Answer

Valacyclovir

Answer

Valganciclovir

Answer

Cidofovir

Question 4

A 15-year-old female with HIV infection on antiretroviral therapy presents with nausea, vomiting, and flank pain. Urine microscopy showed rectangular plate and needle-shaped crystals. Serum creatinine was raised. What is the likely cause?

Accepted Answer

Indinavir

Answer

Ritonavir

Answer

Nevirapine

Answer

Zidovudine

Question 5

Fluconazole differs from ketoconazole in which of the following aspects?

Accepted Answer

It is unlikely to produce anti-androgenic side effects.

Answer

It is not active by the oral route.

Answer

It is a more potent inhibitor of drug metabolism.

Answer

It is not effective in Cryptococcal meningitis.

Question 6

Which of the following drugs is least effective against MRSA?

Accepted Answer

Meropenem

Answer

Teicoplanin

Answer

Quinupristin

Answer

Linezolid

Question 7

What is the oral therapy of choice in MRSA skin infection?

Accepted Answer

Clindamycin

Answer

Dicloxacillin

Answer

Quinupristin

Answer

Dalfopristin

Question 8

Which of the following is NOT a true statement regarding the mechanism of action of the listed antimicrobial agents?

Accepted Answer

Tetracycline inhibits cell wall synthesis.

Answer

Chloramphenicol inhibits protein synthesis.

Answer

Metronidazole damages DNA.

Answer

Penicillin inhibits cell wall synthesis.

Question 9

Which of the following are bactericidal inhibitors of protein synthesis?

Accepted Answer

Aminoglycosides

Answer

Tetracyclines

Answer

Macrolides

Answer

Lincosamides

Question 10

Thalidomide is used in all of the following conditions EXCEPT:

Accepted Answer

HIV neuropathy

Answer

Erythema nodosum leprosum

Answer

HIV associated ulcer

Answer

Multiple myeloma

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?